Leo Cancer Care
UK - CrawleyBiotechnology
Focus: Leo Cancer Care is a Series B biotechnology company specializing in upright radiation therapy for oncology, with a landmark compact proton therapy system (Marie®) recently deployed at Stanford Medicine. The company is early-stage and UK-headquartered, focused on advancing precision cancer treatment technology.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Total Funding
$25.3M
Open Jobs
12+4 this month
Stable — net +4 jobs in 30d
8 added, 4 removed. Backfill posture.
Should You Work at Leo Cancer Care?
AI assessmentAn attractive early-stage oncology technology bet for engineers, IT professionals, and mission-driven scientists willing to accept pre-revenue uncertainty for equity upside and clinical impact.
Why Work Here
- You'll work on a clinically validated, breakthrough medical device (Marie® proton therapy system) with real-world deployment momentum—recent Stanford installation represents world-first compact upright proton therapy.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Leo Cancer Care
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.